High prevalence of abnormal Pap smears among young women co-infected with HIV in rural South Africa - Implications for cervical cancer screening policies in high HIV prevalence populations

South African Medical Journal

Volumn 97, Issue 2, 2007, Pages 120-123

  Gaym, Asheber ^a,b   Mashego, May ^b   Kharsany, Ayesha B M ^b   Walldorf, Jenny ^b,c   Frohlich, Janet ^b   Abdool Karim, Quarraisha ^b,d  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER SCREENING; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEALTH CARE ACCESS; HEALTH CENTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PAPANICOLAOU TEST; PRACTICE GUIDELINE; PREVALENCE; QUESTIONNAIRE; RURAL AREA; SCREENING; SOCIAL ASPECT; SOUTH AFRICA; STATISTICAL SIGNIFICANCE; SUPERINFECTION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DISEASE; UTERINE CERVIX DYSPLASIA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; FEMALE; HIV INFECTIONS; HUMANS; MASS SCREENING; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RURAL POPULATION; SOUTH AFRICA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 33847103044     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Pisani P, Parkin DM, Bray F, Ferlay J. Estimatas of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83(1): 18-29.
2. Gustafsson L, Ponten J, Zack M, Adami HO. International incidence rates of invasive cervical cancer alter introduction of cytological screening. Cancer Causes Control 1997; 8(5): 755-763.
3. Chirenje ZM, Rusakaniko S, Kirumbi L, et al. Situation analysis for cervical cancer diagnosis and treatment in east, central and southern African countries. Bull World Health Organ 2001; 79(2): 127-32.
4. Murthy NS, Agarwal SS, Prabhakar AK, Sharma S, Das DK. Estimation of reduction of lifetime risk of cervical cancer through one life-time screening. Neoplasma 1993; 40(4): 255-258.
5. Mandelblatt JS, Lawrence WF, Gaffikin L, et al. Costs and benefits of different strategies to screen for cervical cancer in less-developed countries. J Natl Cancer Inst 2002; 94(19): 1469-1483.
6. Leroy V, Ladner J, De Clercq A, et al. Cervical dysplasia and HIV type 1 infection in African pregnant women: a cross sectional study, Kigali, Rwanda. The Pregnancy and HIV Study Group (EGE). Sex Transm Infect 1999; 75(2): 103-106.
7. La Ruche G, You B, Mensah-Ado I, et al. Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women. Int J Cancer 1998; 76(4): 480-486.
8. Abercrombie PD, Korn AP. Lower genital tract neoplasia in women with HIV infection. Oncology (Williston Park) 1998; 12(12): 1735-1739; discussion 1742, 1745, 1747.
9. Gichangi PB, Bwayo J, Estambale B, et al. Impact of HIV infection on invasive cervical cancer in Kenyan women. Aids 2003; 17(13): 1963-1968.
10. Chirenje ZM, Loeb L, Mwale M, Nyamapfeni P, Kamba M, Padian N. Association of cervical SIL and HIV-infection among Zimbabwean women in an HIV/STI prevention study. Int J STD AIDS 2002; 13(11): 765-768.
11. UNAIDS. UNAIDS Fact Sheet 2004. Geneva: World Health Organization, 2004.
12. Rogo KO, Omany J, Onyango JN, Ojwang SB, Stendahl U. Carcinoma of the cervix in the African setting. Int J Gynaecol Obstet 1990; 33(3): 249-255.
13. Lancaster EJ, Banach L, Lekalakala T, Mandiwana I. Carcinoma of the uterine cervix: results of Ka-Ngwane screening programme and comparison between the results obtained from urban and other unscreened rural communities. East Afr Med J 1999; 76(2): 101-104.
14. South African Department of Health. Syndromic Case Management of Sexually Transmitted Diseases - Guide for Decision-makers, Health Care Workers and Communicators. Pretoria: Department of Health, 2000. http://www.cadre.org.za/pdf/pdf/WHO_STD.pdf (accessed 13 December 2006).
15. Cohen MS, Pilcher CD. Amplified HIV transmission and new approaches to HIV prevention. J Infect Dis 2005; 191: 1391-1393.
16. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type I. N Engl J Med 2000; 342(13): 921-929.
17. Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005; 191:1403-1409.
18. Wright TC jun, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002; 287(16): 2120-2129.
19. Östör AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993; 12(2): 186-192.
20. Nasiell K, Roger V, Nasiell M. Behavior of mild cervical dysplasia during long-term follow-up. Obstet Gynecol 1986; 67(5): 665-669.
21. Lonky NM, Navarre GL, Saunders S, Sadeghi M, Wolde-Tsadik G. Low-grade Papanicolaou smears and the Bethesda system: a prospective cytohistopathologic analysis. Obstet Gynecol 1995; 85(5 Pt 1): 716-20.
22. Fonn S, Bloch B, Mabina M, et al. Prevalence of pre-cancerous lesions and cervical cancer in South Africa - a multicentre study. S Afr Med J 2002; 92(2): 148-156.
23. Berek JS. Cervical and vaginal cancer In: Berek JS, Hillard, PJA, Adashi EY, ed. Novak's Gynecology. 13th ed. Philadelphia: Lippincott Williams & Wilkins, 2002: 1207.
24. Goff BA, Atanasoff P, Brown E, Muntz HG, Bell DA, Rice LW. Endocervical glandular atypia in Papanicolaou smears. Obstet Gynecol 1992; 79(1): 101-104.
25. Boon ME, Baak JP, Kurver PJ, Overdiep SH, Verdonk GW. Adenocarcinoma in situ of the cervix: an underdiagnosed lesion. Cancer 1981; 48(3): 768-773.